(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione

C44H65FN6O9 — CID 10212935

IUPAC(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione
SMILESCC[C@@H]1OC(=O)C(C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C2=NCN(CCCn3cnc(-c4ccccc4)c3)N3C(=O)O[C@@]1(C)[C@H]3[C@@H]2C
InChIInChI=1S/C44H65FN6O9/c1-12-33-44(8)36-28(4)34(47-25-50(51(36)41(55)60-44)20-16-19-49-23-31(46-24-49)30-17-14-13-15-18-30)26(2)22-42(6,56-11)38(29(5)37(53)43(7,45)40(54)58-33)59-39-35(52)32(48(9)10)21-27(3)57-39/h13-15,17-18,23-24,26-29,32-33,35-36,38-39,52H,12,16,19-22,25H2,1-11H3/t26-,27-,28-,29+,32+,33+,35-,36-,38-,39+,42+,43?,44-/m1/s1
InChIKeyFAUOUIGNKWDKKW-SIXYOMSASA-N
MW841.03 g/mol
LogP5.30
Rot. Bonds10

About (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione

(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione (PubChem CID 10212935) has the molecular formula C44H65FN6O9 and a molecular weight of 841.03 g/mol. Its IUPAC name is (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione.

Molecular Properties

Compound Name(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione
PubChem CID10212935
Molecular FormulaC44H65FN6O9
Molecular Weight841.03 g/mol
Exact Mass840.48
IUPAC Name(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione
SMILESCC[C@@H]1OC(=O)C(C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C2=NCN(CCCn3cnc(-c4ccccc4)c3)N3C(=O)O[C@@]1(C)[C@H]3[C@@H]2C
InChIInChI=1S/C44H65FN6O9/c1-12-33-44(8)36-28(4)34(47-25-50(51(36)41(55)60-44)20-16-19-49-23-31(46-24-49)30-17-14-13-15-18-30)26(2)22-42(6,56-11)38(29(5)37(53)43(7,45)40(54)58-33)59-39-35(52)32(48(9)10)21-27(3)57-39/h13-15,17-18,23-24,26-29,32-33,35-36,38-39,52H,12,16,19-22,25H2,1-11H3/t26-,27-,28-,29+,32+,33+,35-,36-,38-,39+,42+,43?,44-/m1/s1
InChIKeyFAUOUIGNKWDKKW-SIXYOMSASA-N
XLogP5.30
TPSA157.49 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds10
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500841.03
LogP ≤ 55.30
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione?
The IUPAC name of (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione (CID 10212935) is (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione.
What is the SMILES notation for (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione?
The canonical SMILES for (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione is CC[C@@H]1OC(=O)C(C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C2=NCN(CCCn3cnc(-c4ccccc4)c3)N3C(=O)O[C@@]1(C)[C@H]3[C@@H]2C.
What is the InChIKey of (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione?
The InChIKey is FAUOUIGNKWDKKW-SIXYOMSASA-N. The full InChI is InChI=1S/C44H65FN6O9/c1-12-33-44(8)36-28(4)34(47-25-50(51(36)41(55)60-44)20-16-19-49-23-31(46-24-49)30-17-14-13-15-18-30)26(2)22-42(6,56-11)38(29(5)37(53)43(7,45)40(54)58-33)59-39-35(52)32(48(9)10)21-27(3)57-39/h13-15,17-18,23-24,26-29,32-33,35-36,38-39,52H,12,16,19-22,25H2,1-11H3/t26-,27-,28-,29+,32+,33+,35-,36-,38-,39+,42+,43?,44-/m1/s1.
What are the key properties of (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione?
(2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione has a molecular weight of 841.03 g/mol, XLogP of 5.30, 10 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,4S,5R,6R,11S,12S,19S,20R)-5-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-8-fluoro-4-methoxy-2,4,6,8,12,19-hexamethyl-16-[3-(4-phenylimidazol-1-yl)propyl]-10,13-dioxa-15,16,18-triazatricyclo[10.6.2.015,20]icos-1(18)-ene-7,9,14-trione is sourced from PubChem (CID 10212935), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).